Viewing Study NCT06433557


Ignite Creation Date: 2025-12-24 @ 6:41 PM
Ignite Modification Date: 2026-02-23 @ 1:11 AM
Study NCT ID: NCT06433557
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-02
First Post: 2024-05-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
Sponsor: Ascendis Pharma Growth Disorders A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module